NCT01334697View on ClinicalTrials.gov

Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

recombinant human cardiotrophin-1

Single dose intravenous administration

OTHER

Placebo

Single dose intravenous administration

Trial Locations (2)

Unknown

Hosp. Universitario Puerta de Hierro de Majadahonda, Madrid

Clínica Universidad de Navarra, Pamplona

Sponsors

Lead Sponsor

Digna Biotech S.L.
All Listed Sponsors
lead

Digna Biotech S.L.

INDUSTRY